Drugs for Geographic Tongue (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 18)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Doxycycline |
Approved, Investigational, Vet_approved |
Phase 4 |
|
564-25-0 |
54671203
|
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
24390-14-5
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
41411-66-9 (6-epimer, mono-hydrochloride)
564-25-0
5-Hydroxy-alpha-6-deoxytetracycline
5-hydroxy-α-6-deoxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
6alpha-Deoxy-5-oxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-Deoxyoxytetracycline
6-Deoxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
Alti-Doxycycline
Anhydrous doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
Deoxymykoin
DivK1c_000345
DMSC (*Fosfatex)
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
DOXCYCLINE ANHYDROUS
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
DOXY
Doxy-Caps
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
doxycycline
Doxycycline (200mg/day) or Placebo
Doxycycline (anhydrous)
|
Doxycycline (INN)
Doxycycline (internal use)
Doxycycline (TN)
Doxycycline anhydrous
DOXYCYCLINE CALCIUM
Doxycycline hyclate
Doxycycline Hyclate
Doxycycline Monohydrate
DOXYCYCLINE MONOHYDRATE
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxy-Puren
Doxysol
Doxy-Tabs
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
Liviatin
Lopac0_000405
LS-187766
LS-93868
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
Novo-Doxylin
NSC633557
Nu-Doxycycline
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
Spanor
SPBio_000246
SPBio_002784
Spectrum_000807
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
STOCK1N-34341
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Novum
Vibramycine
Vibra-tabs
Vibravenos
Vivox (*Hyclate)
|
|
2 |
|
Cefuroxime |
Approved |
Phase 4 |
|
55268-75-2 |
5479529
5361202
|
Synonyms:
(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(carbamoyloxy)methyl]-7-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime) carbamate (ester)
153012-39-6
3-[(carbamoyloxy)methyl]-7beta-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-3,4-didehydrocepham-4-carboxylic acid
55268-75-2
56238-63-2
AC-15028
AC1NUIFB
AC1Q41FS
AC-4539
Anaptivan
BIDD:GT0619
Biociclin
Biofuroksym
Bioxima
BPBio1_001033
BRD-K02733959-236-02-8
BRN 5783190
BSPBio_000939
C06894
C08108
C16H15N4O8S.Na
C16H16N4O8S
C4417_FLUKA
C4417_SIGMA
Cefofix
Cefumax
Cefurex
Cefuril
Cefuroxim
Cefuroxim AJ
Cefuroxim curasan
Cefuroxim Fresenius
Cefuroxim Genericsn
Cefuroxim Hexal
Cefuroxim Lilly
Cefuroxim MN
Cefuroxim Norcox
Cefuroxim Norcox [inj.]
Cefuroxima Fabra
Cefuroxima Richet
cefuroxime
Cefuroxime
Cefuroxime (TN)
Cefuroxime (USAN/INN)
Cefuroxime [USAN:BAN:INN]
Cefuroxime [USAN:INN:BAN]
CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER
Cefuroxime for Injection and Dextrose for Injection in Duplex Container
cefuroxime na
CEFUROXIME SODIUM
Cefuroxime sodium (JP15/USP)
|
Cefuroxime sodium [USAN:BAN:JAN]
Cefuroxime sodium salt
cefuroximesodium
Cefuroximine
Cefuroximo
Cefuroximo [INN-Spanish]
Cefuroximum
Cefuroximum [INN-Latin]
Cephuroxime
Cetroxil
Cetroxil [inj.]
CHEBI:3515
CHEMBL1436
CID5479529
CID6523269
Colifossim
CPD0-2069
Curocef
Curoxim
Curoxima
Curoxime
CXM
D00262
D00915
EINECS 259-560-1
EINECS 260-073-1
Froxal
Froxal [inj.]
Furoxil
KEFUROX IN PLASTIC CONTAINER
Kesint
Ketocef
KS-1040
Lifurox
LS-149936
LS-2226
Medoxim
MolPort-002-885-814
MolPort-005-938-003
Prestwick3_000720
Sharox
Sharox [inj.]
Sodium (6R-(6alpha,7beta(Z)))-3-(((aminocarbonyl)oxy)methyl)-7-(2-furyl(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Sodium (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), carbamate (ester)
Sodium cefuroxime
Spectrazolr
Ultroxim
UNII-O1R9FJ93ED
UNII-R8A7M9MY61
Zinacef
Zinacef (TN)
Zinacef danmark
Zinacef Danmark
ZINACEF IN PLASTIC CONTAINER
Zinnat [inj.]
|
|
3 |
|
Amoxicillin |
Approved, Vet_approved |
Phase 4 |
|
26787-78-0 |
33613
2171
|
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
Actimoxi
Almodan
alpha-Amino-p-hydroxybenzylpenicillin
Ambap26787-78-0
AMC
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
amoxicillanyl
amoxicillin
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
AMOXICILLIN CRYSTALLINE
Amoxicillin pediatric
AMOXICILLIN PEDIATRIC
Amoxicillin trihydrate
Amoxicillin Trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [inn]
Amoxicilline [INN]
Amoxicilline [INN-French]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxi-mast
Amoxi-Mast
Amoxivet
Amoxycillin
Amoxycillin trihydrate
Amoxycillin Trihydrate
Amoxycillin, BAN
Amoxymed
AMPC
Amrit
Anemolin
Apo-amoxi
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi sugar free
Aspenil
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Biomox
BLP 1410
BL-P 1410
BPBio1_000499
BRD-K55044200-001-03-9
|
Bristamox
BRL 2333
BRL-2333
BSPBio_000453
C06827
Cemoxin
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
Clamoxyl
Clamoxyl (SKB)
CPD000058707
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D07452
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
DB01060
Delacillin
Dispermox
DisperMox
Efpenix
EINECS 248-003-8
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
Hiconcil
Histocillin
HMS1569G15
HSDB 3204
Hydroxyampicillin
Ibiamox
Imacillin
Lamoxy
Larotid
LS-149721
Metafarma capsules
Metifarma capsules
MLS000028632
MLS002222248
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
NSC 277174
NSC277174
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
Pamoxicillin
PHL-amoxicillin
p-Hydroxyampicillin
P-Hydroxyampicillin
Piramox
PMS-amoxicillin
Polymox
Prestwick_713
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
Sauracillin
Sawamox PM
SMR000058707
SPBio_002374
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
α-amino-p-hydroxybenzylpenicillin
|
|
4 |
|
Penicillin V |
Approved, Vet_approved |
Phase 4 |
|
87-08-1 |
6869
|
Synonyms:
(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenoxyacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-{[(phenyloxy)acetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
1098-87-9 (mono-hydrochloride salt)
132-98-9
132-98-9 (mono-potassium salt)
147-48-8 (mono-hydrochloride salt)
2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carbonyl
2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carboxylic acid
3,3-dimethyl-6beta-[(phenoxyacetyl)amino]penam-2alpha-carboxylic acid (PIN)
3,3-Dimethyl-7-oxo-6-((phenyloxyacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
4-27-00-05884 (Beilstein Handbook Reference)
6-phenoxyacetamidopenicillanic acid
6-Phenoxyacetamidopenicillanic acid
87-08-1
AB00514745
AC1L1NHG
AC1Q5QX3
Acipen V
acipen-v
Apocillin
Apopen
AR-1H6492
Beepen-VK
Beromycin
Beromycin, Penicillin
Berromycin, Penicillin
Betapen-VK
Bio-0630
BRD-K43966364-237-02-2
BRN 0096259
BSPBio_002185
C08126
C16H18N2O5S
Calcipen
CCRIS 752
CHEBI:27446
CHEBI:53706
CHEMBL615
CID6869
Compocillin V
Crystapen V
D05411
DB00417
DB08415
Distaquaine V
DivK1c_000779
EINECS 201-722-0
Eskacillian V
Eskacillin V
Fenacilin
Fenospen
Fenossimetilpenicillina
Fenossimetilpenicillina [Dcit]
Fenossimetilpenicillina [DCIT]
Fenoximetilpenicilina
Fenoximetilpenicilina [INN-Spanish]
Fenoxymethylpenicillin
Fenoxypen
HSDB 6314
IDI1_000779
KBio1_000779
KBio2_001487
KBio2_004055
KBio2_006623
KBio3_001685
KBioGR_000944
KBioSS_001487
|
LS-1861
Meropenin
MLS001304105
MolPort-002-515-462
NCGC00159342-02
NINDS_000779
Oracillin
Oratren
Ospen
Penapar-Vk
Penicillin phenoxymethyl
Penicillin Phenoxymethyl
penicillin v
Penicillin V
Penicillin V (USP)
Penicillin V [USAN]
Penicillin V Potassium
Penicillin, Phenoxymethyl
Penicillin-Vk
Pen-Oral
Pen-V
Pen-vee
Phenocillin
Phenomycilline
Phenopenicillin
Phenoximethylpenicillinum
phenoxomethylpenicillanyl
phenoxomethylpenicillin
Phenoxomethylpenicillin
Phenoxymethyl penicillin
Phenoxymethyl Penicillin
Phenoxymethylenepenicillinic acid
Phenoxymethylenepenicillinic Acid
phenoxymethylpenicillanyl
Phenoxymethylpenicillin
Phenoxymethylpenicillin (INN)
Phenoxymethylpenicillin Potassium
Phenoxymethylpenicilline
Phénoxyméthylpénicilline
Phenoxymethylpenicilline [INN-French]
phenoxymethylpenicillinic acid
Phenoxymethylpenicillinic Acid
Phenoxymethylpenicillinic acid potassium salt
Phenoxymethylpenicillinic Acid Potassium Salt
Phenoxymethylpenicillinum
Phenoxymethylpenicillinum [INN-Latin]
P-Mega-Tablinen
PNV
PV
PVA
Robicillin
Rocilin
SMR000539431
SPBio_000389
Spectrum_001007
Spectrum2_000495
Spectrum3_000543
Spectrum4_000472
Spectrum5_001409
Stabicillin
UNII-Z61I075U2W
V-Cil
V-Cillin
V-Cillin (TN)
V-Cillin K
V-Cylina
V-Cyline
Vebecillin
Vegacillin
V-Tablopen
|
|
5 |
|
Anti-Bacterial Agents |
|
Phase 4,Phase 1,Phase 2 |
|
|
|
6 |
|
Anti-Infective Agents |
|
Phase 4,Phase 1,Phase 2 |
|
|
|
7 |
|
Antimalarials |
|
Phase 4 |
|
|
|
8 |
|
Antiparasitic Agents |
|
Phase 4 |
|
|
|
9 |
|
Antiprotozoal Agents |
|
Phase 4 |
|
|
|
10 |
|
cefuroxime axetil |
|
Phase 4 |
|
|
|
11 |
|
Antibiotics, Antitubercular |
|
Phase 4,Phase 1,Phase 2 |
|
|
|
12 |
|
penicillins |
|
Phase 4 |
|
|
|
13 |
|
Ceftriaxone |
Approved |
|
|
73384-59-5 |
5479530
5361919
|
Synonyms:
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
104376-79-6
104376-79-6 (di-hydrochloride salt)
73384-59-5
74578-69-1 (di-hydrochloride salt, hemiheptahydrate)
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
AC-1592
AC1NUIFE
Biotrakson
C06683
C18H18N8O7S3
Cefatriaxone
Ceftriaxon
Ceftriaxona
Ceftriaxona [INN-Spanish]
ceftriaxone
Ceftriaxone (INN)
Ceftriaxone (TN)
Ceftriaxone [USAN:JAN]
Ceftriaxone intravenous
CEFTRIAXONE SODIUM
|
Ceftriaxone, Disodium Salt
Ceftriaxone, Disodium Salt, Hemiheptahydrate
Ceftriaxonum
Ceftriaxonum [INN-Latin]
Ceftriazone
CHEBI:29007
CHEMBL161
CID5479530
CTRX
D07659
DB01212
DRG-0071
EINECS 277-405-6
Longacef
Longaceph
LS-150031
MolPort-005-933-495
Ro 139904
Ro13-9904
Ro-13-9904
Rocefin
Rocephin
Rocephine
UNII-75J73V1629
|
|
14 |
|
Antitubercular Agents |
|
|
|
|
|
15 |
|
Antibodies |
|
|
|
|
|
16 |
|
Immunoglobulins |
|
|
|
|
|
17 |
|
Immunoglobulin A |
|
|
|
|
|
18 |
|
Immunoglobulin M |
|
|
|
|
|
Interventional clinical trials:
(show all 21)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome |
Completed |
NCT01518192
|
Phase 4 |
doxycycline;cefuroxime axetil |
2 |
Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice |
Completed |
NCT01368341
|
Phase 4 |
Doxycycline;Phenoxymethylpenicillin;Amoxicillin |
3 |
Xenodiagnosis After Antibiotic Treatment for Lyme Disease |
Recruiting |
NCT02446626
|
Phase 1, Phase 2 |
|
4 |
The Relationship Between Allergic Rhinitis and Geographic Tongue |
Unknown status |
NCT01454492
|
|
|
5 |
Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis |
Unknown status |
NCT00942006
|
|
doxycycline;ceftriaxone |
6 |
Doxycycline in Therapy of Erythema Migrans |
Completed |
NCT01475708
|
|
Doxycycline |
7 |
Duration of Antibiotic Treatment of Erythema Migrans |
Completed |
NCT00910715
|
|
doxycycline;doxycycline;placebo |
8 |
Culture Media for Borrelia Burgdorferi Sensu Lato |
Completed |
NCT02145754
|
|
|
9 |
Searching for Persistence of Infection in Lyme Disease |
Completed |
NCT01143558
|
Early Phase 1 |
|
10 |
Cytokines and Chemokines in Erythema Migrans |
Recruiting |
NCT02147249
|
|
antibiotic treatment |
11 |
Antibiotic Treatment of Multiple Erythema Migrans |
Recruiting |
NCT01163994
|
|
ceftriaxone;doxycycline |
12 |
Analysis of Lyme Disease Lesions |
Recruiting |
NCT00132327
|
|
|
13 |
Duration of Doxycycline Treatment in EM Patients |
Recruiting |
NCT03153267
|
|
Doxycycline 100 MG Oral Tablet bid, 7 days;Doxycycline 100 MG Oral Tablet bid, 14 days;Controls without a history of lyme disease. |
14 |
Duration of Doxycycline Treatment in MEM Patients |
Recruiting |
NCT03337932
|
|
Doxycycline 100 milligram Oral Tablet bid, 7 days;Doxycycline 100 milligram Oral Tablet bid, 14 days;Controls without a history of lyme disease. |
15 |
Lyme Borreliosis and Early Cutaneous Diagnostic |
Recruiting |
NCT02414789
|
|
|
16 |
Borrelia Species in Cutaneous Lyme Borreliosis |
Recruiting |
NCT00576082
|
|
|
17 |
Sofia 2 Lyme FIA Whole Blood Clinical Study |
Recruiting |
NCT03238274
|
|
|
18 |
Lyme Test Indication Combinations (LyTIC) Study |
Recruiting |
NCT03201042
|
|
|
19 |
Erythema Migrans in Elderly |
Active, not recruiting |
NCT03371563
|
|
Antibiotics |
20 |
Investigation of Southern Tick-Associated Rash Illness (STARI) |
Terminated |
NCT00358761
|
|
|
21 |
A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease |
Terminated |
NCT02741609
|
|
|
|